Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.

Hippisley-Cox J., Tan PS., Coupland C.

DOI

10.1136/heartjnl-2020-318312

Type

Journal article

Journal

Heart (British Cardiac Society)

Publication Date

05/11/2020

Addresses

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK Julia.Hippisley-Cox@phc.ox.ac.uk.

Permalink Original publication